Heikki Joensuu
Heikki Joensuu
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Active, not recruiting | Phase 3 | 2025-03-12 | NCT02413736 |